In her interview, Paula Alves explains the rational behind iNOVA4Health, its aims and the top-level research that is being carried out within the consortium. You can hear the interview here (in Portuguese)
The 2017 ESACT (European Society of Animal Cell Technology) Meeting took place in Lausanne (May 14-17) and focused on the theme "Cell technologies for innovative therapies".
iBET was present at the XVI Portuguese Congress of Nutrition and Food (4-5 May) at the invitation of its shareholder Buggypower08.05.2017
The meeting joined together over 1500 nutritionists, researchers, MDs and other professionals from the agrofood industry to debate topics aligned with inovation, new food sources, metabolic disorders and healthy aging.
Buggypower is a biotechnology company specialized in the design, construction and operation of microalgae production units.
Rosário Bronze, Associate Professor at the School of Pharmacy of the University of Lisbon (FFUL), is head of the Food Functionality and Bioactives Lab at iBET and ITQB NOVA and of the Toxicological and Bromatology Lab at FFUL.
The EC has officially approved the “TRANSVAC2” project. This project has as coordinating institution the European Vaccine Initiative (EWIV) and a maximum grant amount of 10 M€ for 60 months.
Genibet is a CDMO (Contract Development and Manufacturing Organization) created in 2006, with headquarters in Oeiras and that is dedicated to the manufacture of biopharmaceutical products.